• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF IQ TORIC SINGLEPIECE IOL; LENS, INTRAOCULAR, TORIC OPTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF IQ TORIC SINGLEPIECE IOL; LENS, INTRAOCULAR, TORIC OPTICS Back to Search Results
Model Number SN6AT9
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Capsular Bag Tear (2639)
Date of Event 12/28/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The explanted lens was returned positioned incorrectly in the lens case inside the opened carton.Solution and blood was dried on the lens.One haptic was broken from the optic.The broken haptic included a large portion of the optic material.The optic was also pressed down into the well area and against a post of the lens case.Product history records were reviewed and documentation indicated the product met release criteria.Information indicated the use of a qualified cartridge and handpiece.A non-qualified viscoelastic was indicated.The explanted lens was returned with broken haptic damage.The root cause of the reported complaint cannot be determined.Information was provided by the customer that the lens caused the posterior tear.It is unknown if the observed lens damage occurred during the removal of the lens from the eye, or during insertion.A non-qualified viscoelastic was indicated.The ifu instructs that a company qualified delivery system and viscoelastic combination should be used.The use of an unqualified combination may cause damage to the lens and potential complications during the implantation process.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
A materials manager reported that during implantation of an intraocular lens (iol) the posterior capsule tore.The lens was removed to perform vitrectomy.Additional information was received stating the patient was not hospitalized for the event and there was no patient harm.The lens caused the posterior capsule tear.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACRYSOF IQ TORIC SINGLEPIECE IOL
Common Device Name
LENS, INTRAOCULAR, TORIC OPTICS
Manufacturer (Section D)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer (Section G)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key13421550
Report Number1119421-2022-00155
Device Sequence Number6199856
Product Code MJP
UDI-Device Identifier00380652279031
UDI-Public00380652279031
Combination Product (Y/N)N
Initial Reporter StateSC
Initial Reporter CountryUS
PMA/510(K) Number
P930014
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date (Section B) 02/02/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date02/28/2026
Device Model NumberSN6AT9
Device Catalogue NumberSN6AT9.165
Device Lot Number15157673
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/19/2022
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 01/10/2022
Initial Report FDA Received Date02/02/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/02/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
Yes
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
HEALON; MONARCH III IOL DELIVERY SYSTEM, CARTRIDGE D; MONARCH III IOL DELIVERY SYSTEM, INJECTOR
Outcome Attributed to Adverse Event Required Intervention; Other;
Patient Age69 YR
Patient SexMale
-
-